Zobrazeno 1 - 10
of 715
pro vyhledávání: '"Zabotti, A"'
Autor:
Alen Zabotti, Nicola Cabas, Sofia Cacioppo, Caterina Zoratti, Ivan Giovannini, Debora Berretti, Michele Maria Luchetti, Salvatore De Vita, Luca Quartuccio, Giovanni Terrosu, Marco Marino
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1321-1331 (2024)
Abstract Introduction Inflammatory bowel disease (IBD)-related arthritis is recognized as the most prevalent extraintestinal manifestation (EIM) of IBD. The objective of this study was to determine the prevalence and characteristics of undiagnosed IB
Externí odkaz:
https://doaj.org/article/01a14097693a4b90b5a725c488fa160c
Autor:
Andrea Picchianti Diamanti, Maria Sofia Cattaruzza, Simonetta Salemi, Roberta Di Rosa, Giorgio Sesti, Chiara De Lorenzo, Gloria Maria Felice, Bruno Frediani, Caterina Baldi, Maria Sole Chimenti, Arianna D’Antonio, Gloria Crepaldi, Michele Maria Luchetti, Valentino Paci, Alen Zabotti, Ivan Giovannini, Marco Canzoni, Giandomenico Sebastiani, Chiara Scirocco, Carlo Perricone, Bruno Laganà, Annamaria Iagnocco
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1347-1361 (2024)
Abstract Introduction Clinical remission is the main target in the management of patients with rheumatoid arthritis (RA). However, several authors found synovitis in patients with RA in clinical remission at ultrasonography (US). Upadacitinib is a se
Externí odkaz:
https://doaj.org/article/d17f65c67a4f4cf9999e97bded1dc1c1
Autor:
Zabotti A, Cabas N, Giovannini I, Guella S, Cereser L, Zuiani C, Stinco G, Quartuccio L, Errichetti E
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 17, Pp 1553-1556 (2024)
Alen Zabotti,1 Nicola Cabas,1 Ivan Giovannini,1 Silvia Guella,1 Lorenzo Cereser,2 Chiara Zuiani,2 Giuseppe Stinco,3 Luca Quartuccio,1 Enzo Errichetti3 1Department of Medical and Biological Sciences, Rheumatology Institute, Azienda sanitaria universit
Externí odkaz:
https://doaj.org/article/678a648f59444c66a0bab1c33f965644
Autor:
Abdulla Watad, Alen Zabotti, Yonatan Shneor Patt, Omer Gendelman, Arad Dotan, Niv Ben-Shabat, Lior Fisher, Dennis McGonagle, Howard Amital
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 4, Pp 963-976 (2024)
Abstract Introduction Biologic therapies are licensed for both psoriasis (PsO) and psoriatic arthritis (PsA) with some electronic medical record data suggest that IL (Interleukin)-23 blockers might be more protective in PsA prevention than TNF blocke
Externí odkaz:
https://doaj.org/article/7b8d8878a9ff404f81b9300439010617
Autor:
Zabotti, Alen1 (AUTHOR) zabottialen@gmail.com, Cabas, Nicola1 (AUTHOR), Cacioppo, Sofia1 (AUTHOR), Zoratti, Caterina2 (AUTHOR), Giovannini, Ivan1 (AUTHOR), Berretti, Debora3 (AUTHOR), Luchetti, Michele Maria4 (AUTHOR), De Vita, Salvatore1 (AUTHOR), Quartuccio, Luca1 (AUTHOR), Terrosu, Giovanni5 (AUTHOR), Marino, Marco3 (AUTHOR)
Publikováno v:
Rheumatology & Therapy. Oct2024, Vol. 11 Issue 5, p1321-1331. 11p.
Autor:
Benedetta Zabotti, Sara Buchini, Mariarosa Milinco, Adriano Cattaneo, Paola Pani, Luca Ronfani
Publikováno v:
International Breastfeeding Journal, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background The Mothers’ Milk Tool, developed and launched by the Australian National University and Alive & Thrive in 2022, allows to estimate the volume and value of breastmilk using prevalence rates of breastfeeding by month of age from
Externí odkaz:
https://doaj.org/article/d2604b43356c45e1bd812997ed34ecf7
Autor:
Watad, Abdulla1,2,3 (AUTHOR) Watad.Abdulla@gmail.com, Zabotti, Alen4 (AUTHOR), Patt, Yonatan Shneor1,2 (AUTHOR), Gendelman, Omer1,2 (AUTHOR), Dotan, Arad1,2 (AUTHOR), Ben-Shabat, Niv1,2 (AUTHOR), Fisher, Lior1,2 (AUTHOR), McGonagle, Dennis3 (AUTHOR), Amital, Howard1,2 (AUTHOR)
Publikováno v:
Rheumatology & Therapy. Aug2024, Vol. 11 Issue 4, p963-976. 14p.
Autor:
Laure Gossec, Josef S Smolen, Alen Zabotti, Georg Schett, Abdulla Watad, Dennis G McGonagle, Annarita Tullio, Salvatore De Vita, Ivan Giovannini, Enzo Errichetti, Ilaria Tinazzi, Luca Quartuccio, Ettore Silvagni, Filippo Fagni, Gabriele De Marco, David Simon, Michael Sticherling
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objective Subjects with subclinical psoriatic arthritis (PsA), defined as the presence of arthralgia in psoriasis (PsO), are at higher risk of PsA but scant real-world data exist. Our aims were to (1) estimate the probability of PsA development in su
Externí odkaz:
https://doaj.org/article/8971c595d6de4d759a3c2abd481be74c
Autor:
Michele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, Alen Zabotti, Roberta Ramonda, Maria Sole Chimenti, Lorenzo Dagna, Nicoletta Luciano, Anna Piccinelli, Ivan Giovannini, Giovanni Striani, Nicola Boffini, Gilda Sandri, Niccolò Possemato, Ilenia Pantano, Devis Benfaremo, Carlo Salvarani, Francesco Ciccia, Carlo Selmi, Gianluca Moroncini
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-11 (2023)
Abstract Background Upadacitinib (UPA) is a selective JAK inhibitor recently approved for the treatment of psoriatic arthritis (PsA). In this post-approval study, we aimed to evaluate the effectiveness and safety of UPA over 24 weeks and identify cli
Externí odkaz:
https://doaj.org/article/108d482682b9424eb9e04468ca9fdd9d
Autor:
Enzo Errichetti, Alen Zabotti
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/421d76270c1648508c02ae12abd0c8c5